Janney Montgomery Scott LLC Novartis Ag Transaction History

Janney Montgomery Scott LLC

  • $35.8 Billion
  • Q3 2024

A detailed history of Janney Montgomery Scott LLC transactions in Novartis Ag stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 244,998 shares of NVS stock, worth $23.8 Million. This represents 0.08% of its overall portfolio holdings.

Number of Shares
244,998
Previous 248,911 1.57%
Holding current value
$23.8 Million
Previous $26.5 Million 6.34%
% of portfolio
0.08%
Previous 0.08%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024
SELL
$106.13 - $120.89 $415,286 - $473,042
-3,913 Reduced 1.57%
244,998 $28.2 Million
Q2 2024

Jul 25, 2024
SELL
$92.57 - $107.37 $356,394 - $413,374
-3,850 Reduced 1.52%
248,911 $26.5 Million
Q1 2024

May 01, 2024
SELL
$95.27 - $108.47 $647,359 - $737,053
-6,795 Reduced 2.62%
252,761 $24.5 Million
Q4 2023

Feb 07, 2024
SELL
$92.27 - $101.54 $677,723 - $745,811
-7,345 Reduced 2.75%
259,556 $26.2 Million
Q3 2023

Nov 08, 2023
SELL
$94.73 - $105.13 $1.04 Million - $1.16 Million
-10,995 Reduced 3.96%
266,901 $27.2 Million
Q2 2023

Jul 26, 2023
BUY
$92.52 - $104.91 $455,938 - $516,996
4,928 Added 1.81%
277,896 $28 Million
Q1 2023

Apr 28, 2023
SELL
$80.03 - $92.81 $2.59 Million - $3 Million
-32,341 Reduced 10.59%
272,968 $25.1 Million
Q4 2022

Feb 01, 2023
BUY
$75.55 - $92.52 $428,595 - $524,865
5,673 Added 1.89%
305,309 $27.7 Million
Q3 2022

Oct 25, 2022
BUY
$74.61 - $87.26 $361,112 - $422,338
4,840 Added 1.64%
299,636 $22.8 Million
Q2 2022

Aug 03, 2022
BUY
$80.52 - $93.75 $179,962 - $209,531
2,235 Added 0.76%
294,796 $24.9 Million
Q1 2022

May 04, 2022
BUY
$80.11 - $90.62 $3.76 Million - $4.25 Million
46,946 Added 19.11%
292,561 $25.7 Million
Q4 2021

Jan 27, 2022
SELL
$79.7 - $88.13 $127,440 - $140,919
-1,599 Reduced 0.65%
245,615 $21.5 Million
Q3 2021

Oct 29, 2021
BUY
$81.78 - $95.14 $767,832 - $893,269
9,389 Added 3.95%
247,214 $20.2 Million
Q2 2021

Jul 26, 2021
BUY
$85.24 - $94.15 $609,466 - $673,172
7,150 Added 3.1%
237,825 $21.7 Million
Q1 2021

Apr 27, 2021
SELL
$83.5 - $98.47 $126,836 - $149,575
-1,519 Reduced 0.65%
230,675 $19.7 Million
Q4 2020

Jan 25, 2021
SELL
$78.07 - $94.43 $658,364 - $796,328
-8,433 Reduced 3.5%
232,194 $21.9 Million
Q3 2020

Nov 06, 2020
SELL
$82.14 - $91.0 $395,257 - $437,892
-4,812 Reduced 1.96%
240,627 $20.9 Million
Q2 2020

Jul 23, 2020
SELL
$80.93 - $91.1 $757,909 - $853,151
-9,365 Reduced 3.68%
245,439 $21.4 Million
Q1 2020

Apr 30, 2020
SELL
$70.67 - $99.01 $180,208 - $252,475
-2,550 Reduced 0.99%
254,804 $21 Million
Q4 2019

Jan 21, 2020
BUY
$84.35 - $95.37 $767,838 - $868,153
9,103 Added 3.67%
257,354 $24.4 Million
Q3 2019

Oct 29, 2019
BUY
$85.54 - $94.26 $463,883 - $511,171
5,423 Added 2.23%
248,251 $21.6 Million
Q2 2019

Jul 29, 2019
BUY
$75.4 - $92.8 $986,835 - $1.21 Million
13,088 Added 5.7%
242,828 $22.2 Million
Q1 2019

Apr 30, 2019
BUY
$75.32 - $86.15 $1.05 Million - $1.21 Million
13,994 Added 6.49%
229,740 $22.1 Million
Q4 2018

Feb 01, 2019
BUY
$73.66 - $82.02 $412,864 - $459,722
5,605 Added 2.67%
215,746 $18.5 Million
Q3 2018

Nov 05, 2018
BUY
$66.94 - $77.43 $1.65 Million - $1.91 Million
24,611 Added 13.27%
210,141 $18.1 Million
Q2 2018

Jul 24, 2018
SELL
$64.91 - $73.36 $76,593 - $86,564
-1,180 Reduced 0.63%
185,530 $14 Million
Q1 2018

Apr 19, 2018
BUY
$70.39 - $84.15 $686,795 - $821,051
9,757 Added 5.51%
186,710 $15.1 Million
Q4 2017

Feb 14, 2018
BUY
$72.33 - $77.64 $897,181 - $963,046
12,404 Added 7.54%
176,953 $14.9 Million
Q3 2017

Nov 15, 2017
BUY
$74.14 - $77.27 $12.2 Million - $12.7 Million
164,549
164,549 $14.1 Million

Others Institutions Holding NVS

# of Institutions
1,437
Shares Held
131M
Call Options Held
1.12M
Put Options Held
1.83M
View Full List

About NOVARTIS AG

NVS Quotes by TradingView
  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $209B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Janney Montgomery Scott LLC Portfolio

Follow Janney Montgomery Scott LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email